“There is a real cost to moving fast”: Using AI to accelerate drug discovery

This blog post features a podcast episode where Ben Popper speaks with Maureen Makes and Ellen Brandenberger about the impact of AI on drug discovery, discussing the challenges of scaling and integrating AI technologies into the process, and emphasizing the need for innovation in meeting industry standards.